Yüksel, M. Et Al. 2019. CAN THE DRUGS USED BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT) HAVE IMPACT ON CMV REACTIVATION THAT RESULTS IN DECREASED OS IN MYELOMA PATIENTS AFTER ASCT?. 7th International Congress on Leukemia Lymphoma Myeloma , (İstanbul, Turkey), 59.

Yüksel, M., Cengiz Seval, G., Uslu, A., Kırcalı, E., Koyun, D., Öztürk, C., ... Çınar, G.(2019). CAN THE DRUGS USED BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT) HAVE IMPACT ON CMV REACTIVATION THAT RESULTS IN DECREASED OS IN MYELOMA PATIENTS AFTER ASCT? . 7th International Congress on Leukemia Lymphoma Myeloma (pp.59). İstanbul, Turkey

Yüksel, MELTEM Et Al. "CAN THE DRUGS USED BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT) HAVE IMPACT ON CMV REACTIVATION THAT RESULTS IN DECREASED OS IN MYELOMA PATIENTS AFTER ASCT?," 7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2019

Yüksel, MELTEM Et Al. "CAN THE DRUGS USED BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT) HAVE IMPACT ON CMV REACTIVATION THAT RESULTS IN DECREASED OS IN MYELOMA PATIENTS AFTER ASCT?." 7th International Congress on Leukemia Lymphoma Myeloma , İstanbul, Turkey, pp.59, 2019

Yüksel, M. Et Al. (2019) . "CAN THE DRUGS USED BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT) HAVE IMPACT ON CMV REACTIVATION THAT RESULTS IN DECREASED OS IN MYELOMA PATIENTS AFTER ASCT?." 7th International Congress on Leukemia Lymphoma Myeloma , İstanbul, Turkey, p.59.

@conferencepaper{conferencepaper, author={MELTEM YÜKSEL Et Al. }, title={CAN THE DRUGS USED BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT) HAVE IMPACT ON CMV REACTIVATION THAT RESULTS IN DECREASED OS IN MYELOMA PATIENTS AFTER ASCT?}, congress name={7th International Congress on Leukemia Lymphoma Myeloma}, city={İstanbul}, country={Turkey}, year={2019}, pages={59} }